Implications of alternative definitions of prediabetes for prevalence in U.S. adults

Diabetes Care

Volumn 34, Issue 2, 2011, Pages 387-391

  James, Cherie ^a   Bullard, Kai Mckeever ^b   Rolka, Deborah B ^b   Geiss, Linda S ^b   Williams, Desmond E ^b   Cowie, Catherine C ^c   Albright, Ann ^b   Gregg, Edward W ^b  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEALTH SURVEY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROBABILITY; SEX RATIO; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NUTRITION SURVEYS; PREDIABETIC STATE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 79951707720     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1314     Document Type: Article

References (25)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
2. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240
3. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-1850 (Pubitemid 41071098)
4. Smith NL, Barzilay JI, Shaffer D, et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002;162:209-216 (Pubitemid 34098191)
5. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
6. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
7. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
8. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
9. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1197
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl. 1):S5-S20
12. Centers for Disease Control and Prevention National Center for Health Statistics. National Health and Nutrition Examination Survey 2005-2006. Questionnaires, Datasets and Related Documentation. Available from http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/nhanes05-06.htm. Accessed 20 September 2009
13. Centers for Disease Control and Prevention National Center for Health Statistics. National Health and Nutrition Examination Survey 2007-2008. Questionnaires, Datasets and Related Documentation. Available from http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/nhanes07-08.htm. Accessed 20 September 2009
14. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 2002;19:708-723 (Pubitemid 35013848)
15. Williams JW, Zimmet PZ, Shaw JE, et al. Gender difference in the prevalence of impaired glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med 2003;20:915-920 (Pubitemid 41701491)
16. Perreault L, Ma Y, Dagogo-Jack S, et al.; Diabetes Prevention Program. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care 2008;31:1416-1421
17. Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010;33:2190-2195
18. Christensen DL, Witte DR, Kaduka L, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010;33:580-582
19. Lorenzo C, Wagenknecht LE, Hanley AJG, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010;33:2104-2109
20. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010;33:2184-2189
21. Mostafa SA, Khunti K, Srinivasan BT, Webb D, Gray LJ, Davies MJ. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1C, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract 2010;90:100-108
22. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1C levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010;152:770-777
23. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. Is haemoglobin A1C a step forward for diagnosing diabetes? BMJ 2009;339:b4432
24. Borch-Johnsen K, Colagiuri S. Diagnosing diabetes - time for a change? Diabetologia 2009;52:2247-2250
25. Herman WH, Ma Y, Uwaifo G, et al.; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-2457